Prevention of bacteremias caused by alpha-hemolytic streptococci by roxithromycin in patients treated with intensive cytotoxic treatment.
Dekker
A W
AW
Department of Hematology, University Hospital Utrecht, The Netherlands.
Rozenberg-Arska
M
M
Verdonck
L F
LF
D000208:Acute Disease; D000328:Adult; D000380:Agranulocytosis / Q000209:etiology; D000666:Amphotericin B / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D002939:Ciprofloxacin / Q000627:therapeutic use; D003131:Combined Modality Therapy; D004341:Drug Evaluation; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D006801:Humans; D007938:Leukemia / Q000150:complications* / Q000628:therapy; D015575:Roxithromycin / Q000627:therapeutic use*; D018805:Sepsis / Q000209:etiology / Q000517:prevention & control*; D013290:Streptococcal Infections / Q000209:etiology / Q000517:prevention & control*
D015575:Roxithromycin; D002939:Ciprofloxacin; D000666:Amphotericin B